Item 8.01 Other Events.



On November 24, 2021, Supernus Pharmaceuticals, Inc. (the "Company") issued a press release regarding a recent ransomware incident. The incident had no significant impact on the Company's business and did not cause any serious disruption to the Company's operations. A copy of the press release is filed as Exhibit 99.1 hereto, and the text of such press release is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.






(d) Exhibits



Exhibit                                Description

  99.1     Press Release dated November 24, 2021.

104      Cover Page Interactive Data File (the cover page XBRL tags are embedded
         within the Inline XBRL document).

© Edgar Online, source Glimpses